These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 28109780)

  • 41.
    Canseco-Alba A; Rodríguez-Manzo G
    Rev Invest Clin; 2023; 75(3):105-128. PubMed ID: 37441766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Examining the role of cannabinoids on osteoporosis: a review.
    Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK
    Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
    Breijyeh Z; Jubeh B; Bufo SA; Karaman R; Scrano L
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33562446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cannabis and Endocannabinoid Signaling in Epilepsy.
    Katona I
    Handb Exp Pharmacol; 2015; 231():285-316. PubMed ID: 26408165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023.
    Lewis M; Baroutian S; Hanning SM
    Curr Pain Headache Rep; 2024 Mar; 28(3):109-118. PubMed ID: 38095748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The case for medical marijuana in epilepsy.
    Maa E; Figi P
    Epilepsia; 2014 Jun; 55(6):783-6. PubMed ID: 24854149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
    Fasinu PS; Phillips S; ElSohly MA; Walker LA
    Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabinoid treatments in epilepsy and seizure disorders.
    Devinsky O; Jones NA; Cunningham MO; Jayasekera BAP; Devore S; Whalley BJ
    Physiol Rev; 2024 Apr; 104(2):591-649. PubMed ID: 37882730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phytocannabinoid Pharmacology: Medicinal Properties of
    Sampson PB
    J Nat Prod; 2021 Jan; 84(1):142-160. PubMed ID: 33356248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite.
    Spanagel R; Bilbao A
    Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cannabinoids in epilepsy: clinical efficacy and pharmacological considerations.
    Espinosa-Jovel C
    Neurologia (Engl Ed); 2023; 38(1):47-53. PubMed ID: 34824031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cannabis sativa: Much more beyond Δ
    Alves P; Amaral C; Teixeira N; Correia-da-Silva G
    Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
    Weinstein A; Livny A; Weizman A
    Curr Pharm Des; 2016; 22(42):6366-6379. PubMed ID: 27549374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies.
    Vimal D; D'Souza LC; Rai V; Lal S; Sharma A; Gupta SC
    Curr Med Chem; 2023; 30(2):178-202. PubMed ID: 35619266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cannabis, cannabidiol, and epilepsies: the truth is somewhere in the middle.
    Sirven JI
    Epilepsy Behav; 2014 Dec; 41():270-1. PubMed ID: 25248668
    [No Abstract]   [Full Text] [Related]  

  • 57. Cannabis cultivation: Methodological issues for obtaining medical-grade product.
    Chandra S; Lata H; ElSohly MA; Walker LA; Potter D
    Epilepsy Behav; 2017 May; 70(Pt B):302-312. PubMed ID: 28202406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ
    Gunasekera B; Davies C; Martin-Santos R; Bhattacharyya S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):636-645. PubMed ID: 33414100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical uses of cannabis and cannabinoids in the United States.
    Levinsohn EA; Hill KP
    J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.